Local med tech company raises cash for commercialisation
The wrong IV drugs kill and maim more than 500 New Zealanders each year. A start-up founded by TIN100 principal Greg Shanahan is trying to help. With special feature audio.
Hot Topic
NBR Focus: GMO
Devonport-based medical technology company Veriphi is raising up to $2 million on equity crowdfunding platform Snowball Effect, as it moves toward commercialisation of its patient safety product.
The start-up has developed laser technology, which it hopes will prevent numerous New Zealanders dying
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
NZ$399.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Tue, 19 Apr 2016
Tue, 19 Apr 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Local med tech company raises cash for commercialisation
57407